Xellia Pharmaceuticals has acquired manufacturing facilities in Bedford, OH from a subsidiary of Hikma Pharmaceuticals, which will increase its production capacity for sterile injectable products in the U.S. Xellia has acquired substantial parts of the site including several new manufacturing units for sterile injectables, which are not currently operational. Hikma will retain the remaining facilities including the quality and development center, which has been operated by its subsidiary, Wes...